Document is current
Any future updates will be listed below
-
Authors
Wynn, Adriane https://orcid.org/0000-0001-8067-3616
Mussa, Aamirah
Ryan, Rebecca
Hansman, Emily
Simon, Selebaleng
Bame, Bame
Moreri-Ntshabele, Badani
Ramogola-Masire, Doreen
Klausner, Jeffrey D.
Morroni, Chelsea
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04955717 at ClinicalTrials.govDocuments that mention this clinical trial
Evaluating the diagnosis and treatment of Chlamydia trachomatis and Neisseria gonorrhoeae in pregnant women to prevent adverse neonatal consequences in Gaborone, Botswana: protocol for the Maduo study
https://doi.org/10.1186/s12879-022-07093-z
Effect of antenatal<i>Chlamydia trachomatis</i>and<i>Neisseria gonorrhoeae</i>screening on postdelivery prevalence and vertical transmission in Gaborone, Botswana: findings from an exploratory study
https://doi.org/10.1136/sextrans-2023-055965
-
Funding
Funding for this research was provided by:
National Institute of Child Health and Human Development (R21 HD100821-01)
National Institute on Alcohol Abuse and Alcoholism (K01AA027733-01)
- License Information
-
More Information
Article History
Received: 23 November 2021
Accepted: 26 January 2022
First Online: 7 March 2022
Declarations
:
: Ethical approval: The trial protocol has been approved by the Institutional Review Boards at the Botswana Ministry of Health and Wellness Health Research Development Committee (HRDC number 00881) and through a reliance agreement with the Institutional Review Board (IRB) of University of Southern California (USC IRB# HS-21-00245). Confidentiality<i>:</i> Every effort will be made to ensure participant confidentiality throughout this study. All participants will receive a unique personal identification code that will be used for data that is entered and stored in electronic records. Names and identifying information will be only be recorded in the study linking form used to link the data to the subject’s personal identification code, and on signed study informed consent forms. Those forms will be stored separately from the devices containing the electronic data in a locked filing cabinet in a locked research office. Consent to participate<i>:</i> Prior to enrollment, all participants will be required to complete written informed consent. Information and consent procedures will be conducted in Setswana or English, as preferred by the individual participant. Women who are unable to read and/or write will be required to have an impartial witness present during the above procedures. Women aged 15–17 years of age will be eligible to participate with verbal parental consent. Parents or guardians of interested 15–17-year olds will be notified if their child is interested in participating and verbal consent will be obtained over the phone and documented.
: Not applicable.
: No competing interesting were disclosed.
